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ABSTRACT
Background: The indications and benefits of laparo-
scopic cholecystectomy (LC) in patients with liver cirrho-
sis and symptomatic cholelithiasis have not been satisfac-
torily documented. The aim of this study was to
investigate its efficacy and safety in such patients.
Methods: Medical records of 38 patients with liver cirrho-
sis (stages Child-Pugh A and B) who underwent LC were
retrospectively reviewed. Demographic characteristics
and other parameters including initial presentation, con-
version rate, complication rate, mortality, and duration of
hospital stay were investigated and compared with non-
cirrhotic patients’ parameters in our database.
Results: Cirrhotic patients who underwent LC were older
than noncirrhotic patients (P0.021). Both the conversion
rate (15.78%) and the duration of hospital stay were in-
creased in the cirrhotic group, but without significant
differences. Major complications occurred more often in
the cirrhotic group (P0.027), increasing morbidity; how-
ever, the mortality was zero.
Conclusions: LC can be safely performed in Child-Pugh
A and B cirrhotic patients with symptomatic gallstone
disease, with acceptable complication and conversion
rates. The increased risk for a major complication, how-
ever, demands more attention than usual.
Key Words: Laparoscopic cholecystectomy, Cholelithia-
sis, Gallstone disease, Liver Cirrhosis, Surgical care, Gall-
bladder.
INTRODUCTION
Since its introduction in the late 1980s, laparoscopic cho-
lecystectomy (LC) has rapidly changed the face of modern
surgery and has become the treatment of choice for symp-
tomatic cholelithiasis. Improvements in operating skills
and equipment have gradually permitted its application in
several previously contraindicated circumstances. Al-
though some well-defined risk factors influencing the
conversion rate have been described,1 LC has been per-
formed safely in various “difficult” conditions, even in the
extremely elderly.2
It is known that cholelithiasis appears with an increased
prevalence in cirrhotic patients, a fact that can be attrib-
uted to a decrease in bile salt production or to elevation of
unconjugated bilirubin. Patients with liver cirrhosis, how-
ever, have been considered poor candidates for LC, espe-
cially those with end-stage disease and portal hyperten-
sion; the latter was initially regarded as a contraindication
to laparoscopic cholecystectomy.3 The hardness of the
fibrotic liver and the increased vasculature secondary to
portal hypertension with a high risk for bleeding are the 2
main operative problems that must be overcome during
the procedure. Over the years, accumulating experience
in LC has resulted in an increasing number of authors
reporting that LC can be safely performed in cirrhotic
patients.4
This retrospective study, which is based on our long
experience, evaluates the outcome of LC in the subgroup
of patients with liver cirrhosis, highlighting operative haz-
ards and its overall efficacy and safety.
METHODS
From January 1993 to August 2008, a total of 1478 patients
underwent LC for symptomatic gallstone disease. Among
them, 38 patients (2.57%) had liver cirrhosis (group C).
Patients who had a clinical history and positive biopsy for
cirrhosis as well as those who were found to be cirrhotic
at the time of the surgery were included in this group. We
retrospectively reviewed the medical records of group C
patients and compared their characteristics with those of
noncirrhotic patients (group NC).
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SCIENTIFIC PAPERInvestigated data included demographic characteristics
(age and sex), Child-Pugh classification, positive history of
either hepatitis B, C, or dual infection, presentation of the
disease (biliary colic or acute cholecystitis), rate of con-
version to open cholecystectomy, major complications,
and duration of hospital stay. A summary of the clinico-
pathological characteristics of the cirrhotic patients is pre-
sented in Table 1.
The diagnosis of cholelithiasis was confirmed by abdom-
inal ultrasonography in all cirrhotic patients. Preoperative
preparation of patients with coagulopathy included ad-
ministration of either fresh frozen plasma in cases of
prolonged prothrombin time (PT) or platelets in cases of
thrombocytopenia. The standard 4-trocar “American tech-
nique” was applied, with few manipulations to minimize
operative trauma. By placing the umbilical trocar on the
right or left of the median line, injuries to recanalized
umbilical veins can be avoided. Transillumination of the
abdominal wall during trocar placement aided in identifi-
cation of abdominal wall vessels and helped to avoid
troublesome bleeding. The procedure progressed with
meticulous dissection and complete hemostasis by mak-
ing use of monopolar electrocautery or titanium clips in
case of large vessels.
Numerical data were compared using the independent
samples t test, while nominal data were compared using
either the Pearson x
2 test or Fisher’s exact test, where
appropriate. All statistical analyses were computed using
SPSS software (SPSS Inc., Chicago, IL, USA). Statistical
significance was considered when P0.05.
RESULTS
Group C included 14 men (36.8%) and 24 women (63.2%).
Male patients represented 29.8% and female patients
70.2% of the total number of NC patients. No statistical
difference was found between the 2 groups (P0.450).
The mean age of group C was 62.3913.3 years (range, 28
to 80). That was significantly higher (P0.021) than the
mean age of group NC (54.0815.4 years).
Twelve group C patients (31.6%) had either a history of
hepatitis B infection or a positive test for HbsAg. The rate
of hepatitis C infected patients was even higher (34.2%); 2
patients had dual infection. Clinical presentation of gall-
stone disease in cirrhotic patients was biliary colic in 31
(81.6%) patients or acute cholecystitis in 7 (18.4%) pa-
tients. In the NC group, 59 patients were operated on for
acute cholecystitis (4.09%). They were fewer than those in
the C group, with a statistically significant difference
(P0.001).
Conversion of laparoscopic cholecystectomy to an open
procedure was necessary in 6 patients in the C group
(15.78%); this rate was higher (almost twice) than the
conversion rate in the NC group (8.75%), but without a
statistical difference between them (P0.104). LC was
converted in cirrhotic patients, because of the inability to
clearly identify local anatomy due to dense fibrosis in
Calot’s triangle in 2 cases and because of extensive adhe-
sions in one case. In 2 patients, conversion was necessary
because of bleeding from the gallbladder bed and in one
patient because of bleeding from an epiploic vessel injury
during the insertion of the Veress needle. The Veress
needle technique to establish pneumoperitoneum has
been abandoned in the last 4 years; direct vision using the
open technique (Hasson’s method) was applied instead.
Three major postoperative complications (7.89%) were
encountered in cirrhotic patients. A duodenal perforation
with peritonitis was treated with reoperation. Two cases
of continuing hemorrhage from the gallbladder bed were
managed conservatively with erythrocyte and fresh frozen
plasma transfusions. In one of them, a reoperation was
required for hemostasis. The above-mentioned complica-
tion rate of 7.89% is significantly higher (P0.027) than
that in the NC group (1.59%). The difference in postoper-
ative mortality was not significant between groups. No
deaths occurred in the C group, whereas 2 deaths oc-
curred in the NC group. Hospitalization time was not
significantly (P0.058) longer in the C group (mean time,
4.43.6 days), than in the NC group (mean time,
2.972.35 days). A synopsis of the perioperative results is
shown in Table 2.
DISCUSSION
The prevalence and incidence of cholelithiasis in patients
with liver cirrhosis is 2 times higher than that in noncir-
rhotic patients.5,6 In these patients, gallstone formation is
Table 1.
Clinicopathological Characteristics of Patients With Liver
Cirrhosis Who Underwent Laparoscopic Cholecystectomy
Characteristic No.
Age 62.3913.26
Sex (Male/Female) 14/24
Child-Pugh classification (A/B/C) 29/9/0
Hepatitis (B/C/C) 12/13/3
Presentation (chronic/acute) 31/7
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elevated levels of unconjugated bilirubin, which are pos-
sibly caused by intravascular hemolysis and/or functional
gallbladder alterations.7 LC, although it was once contra-
indicated for cirrhotic patients, has gradually replaced
open cholecystectomy as the standard of care of gallstone
disease in cirrhotic patients. Such patients can actually
benefit from less intraoperative blood loss, less postoper-
ative pain, and quicker recovery, the major advantages of
the laparoscopic technique. Open surgery is associated
with increased morbidity and mortality,7,8 and results in
more adhesions than a laparoscopic procedure. This latter
can be of significant importance in cirrhotic patients,
which may potentially become candidates for transplan-
tation. Previous open cholecystectomy can be the cause of
increased hypervascular adhesions, which makes the dis-
section of porta hepatis more hazardous.9
In this study, mortality was zero in the cirrhosis group
without any significant difference between the 2 groups.
Major complications occurred significantly more often in
the cirrhosis group, but the increased morbidity did not
reflect on the duration of hospital stay or on the conver-
sion rate, which were both longer but without significant
differences. Similar results are demonstrated in a large
metaanalysis, which compares the results of LC in cirrhotic
patients with LC in noncirrhotic patients and laparoscopic
to open cholecystectomy in cirrhotic patients.9
The technical problems that were encountered intraoper-
atively in our patients resulted in conversion to an open
procedure in 15.78% of cases, almost twice more often
than in the NC group. A similar outcome was reported in
another study.10
The major causes of postoperative morbidity and mortality
in cirrhotic patients are the excessive blood loss, liver
failure, and sepsis. Increased bleeding is the most feared
complication. It is mainly due to either coagulopathy re-
sulting from inadequate synthesis of clotting factors,
thrombocytopenia secondary to hypersplenism, or to ab-
dominal varices of portal hypertension.11 Cirrhotic pa-
tients who underwent LC had significantly increased
blood loss compared with noncirrhotic patients, but less
than the cirrhotic patients who underwent an open pro-
cedure.9 In our series, half of the reasons for conversion
and 2 out of the 3 postoperative complications were
related to uncontrolled bleeding. Bleeding disorders can
be significantly avoided with routine administration of
fresh frozen plasma or platelets preoperatively. Needless
to say, the laparoscopic technique produces less bleeding
than a right subcostal incision. Furthermore, abdominal
wall vessel injury can be avoided by wall transillumina-
tion, and venous bleeding can be controlled by decreas-
ing the pressure of pneumoperitoneum as required.12
The increased risk for postoperative liver failure can be
partially explained by the anesthetic agent’s action, which is
known to decrease hepatic arterial blood flow. This hepatic
ischemia can be the cause of the release of inflammatory
mediators that can lead to multisystem organ failure. The
ability of cirrhotic patients to compensate for this ischemia is
impaired, so hepatic dysfunction can develop postoperative-
ly.13 Impaired liver function in cirrhosis leads to diminished
Kupffer cell function, which in turn leads to reduced intra-
vascular clearance of the enteric organisms and endotoxine-
mia.14 This can explain the increased risk of infection in
cirrhotic patients, which is also directly correlated with the
patient’s Child-Pugh classification.14,15 Additionally, ascitic
fluid is an excellent growth medium for bacterial contami-
nants released in cholecystectomy. Fortunately, infected as-
cites is far less frequent in LC than in open surgery, because
bacterial contamination of the peritoneal cavity through the
5-mm or 10-mm ports does not occur as easily as contami-
nation through a wide right subcostal incision.16
The present study does not include Child-Pugh class C
patients. The fact that mortality and morbidity rates are
higher in this subgroup makes surgeons reluctant to at-
tempt LC. These patients, along with other high-risk pa-
tients can benefit from alternative procedures like percu-
taneous cholecystostomy or subtotal cholecystectomy.
Even though experience is limited, authors reported fa-
Table 2.
Perioperative Results of Cirrhotic and Noncirrhotic Patients Who Underwent Laparoscopic Cholecystectomy
Parameter Cirrhotic Patients (%) (n  38) Noncirrhotic Patients (%) (n  1440) P
Conversion rate 6 (15.78) 126 (8.75) 0.104
Major complications 3 (7.89) 23 (1.59) 0.027
Mortality 0 (0) 2 (0.13) 1.0
Hospital stay 4.403.59 2.972.35 0.058
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rationale of “less is more.”17,18
CONCLUSION
Based on our results, we can conclude that LC can be
performed in Child-Pugh A and B patients with symptom-
atic gallstone disease, with acceptable complication and
conversion rates, morbidity and mortality. The increased
risk for a major complication however, demands more
attention than usual.
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